Mitsuhiro Rokuda
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 19, 2023
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai
|Dec 12, 2023
Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on liver function in patients with type 2 diabetes in Japan: A real-world data analysis.Hirokazu Takahashi, Keiko Asakawa, Yoshinori Kosakai
|Dec 14, 2022
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai
|Mar 10, 2022
Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4).Yoshiya Tanaka, Tsutomu Takeuchi, Daisuke Kato
|Dec 17, 2021
A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years.Yoshiya Tanaka, Tsutomu Takeuchi, Daisuke Kato
|Oct 14, 2020
A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years.Tsutomu Takeuchi, Yoshiya Tanaka, Mitsuhiro Rokuda
Pageof 1
